Antitumor activity of biflavonoids from Ouratea and Luxemburgia on human cancer cell lines

Indian Journal of Pharmacology

Volumn 39, Issue 4, 2007, Pages 184-186

  Daniel, Juliana ^a   Alves, Cassia ^a   Grivicich, Ivana ^b   Da Rocha, Adriana ^b   De Carvalho, Mário ^a  

^a FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Antitumor agents; Biflavonoids; Cancer cell lines; Luxemburgia; Ouratea

Indexed keywords

7'' METHYLAGATHISFLAVONE; 7,7'' DIMETHYLLANARAFLAVONE; AGATHISFLAVONE; ETOPOSIDE; FLAVONE DERIVATIVE; LUXENCHALCONE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN HT29; CELL STRAIN MCF 7; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG MIXTURE; HUMAN; HUMAN CELL; IC 50; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; LUXEMBURGIA OCTANDRA; MEDICINAL PLANT; OURATEA HEXASPERMA; OVARY ADENOCARCINOMA; PLANT LEAF;

EID: 35548943112     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.36536     Document Type: Article

References (23)

1. da Rocha AB, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol 2001;1:364-9.
2. Schwartsmann G, Brondani da Rocha A, Berlinck RG, Jimeno J. Marine organisms as a source of new anticancer agents. Lancet Oncol 2001;2:221-5.
3. Mans DR, da Rocha AB, Schwartsmann G. Anti-cancer drug discovery and development in Brazil: Targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. Oncologist 2000;5:185-98.
4. Newman DJ, Cragg GM, Snader KM. The influence of natural products upon drug discovery. Nat Prod Rep 2000;17:215-34.
5. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol 2005;100:72-9.
6. Daniel JF, Carvalho MG de, Cardoso RS, Agra MF, Eberlin MN. Others flavonoids from Ouratea hexasperma (Ochnaceae). J Braz Chem Soc 2005;16:634-8.
7. Carvalho MG de, Alves CC, Da Silva KG, Eberlin MN, Werle AA. Luxenchalcone, a New Bichalcone and other Constituents from Luxemburgia octandra. J Braz Chem Soc 2004;15:146-9.
8. Carvalho MG de, De Oliveira MCC, Werle AA. Chemical constituents from Luxemburgia nobilis (EICHL). J Braz Chem Soc 2000;11:232-6.
9. Oliveira MC de, Carvalho MG de, Da Silva CJ, Werle AA. New Biflavonoid and other constituents from Luxemburgia nobilis (EICHL). J Braz Chem Soc 2002;13:119-23.
10. Moreira IC, Sobrinho DC, Carvalho MG de, Braz-filho R. Isoflavanone dimmers hexaspermone A, B and C from Ouratea hexasperma. Phytochemistry 1994;35:1567-72.
11. Moreira IC, Carvalho MG de, Bastos ABFO, Braz-Filho R. A flavone dimer from Ouratea hexasperma. Phytochemistry 1999;51:833-8.
12. Velandia JR, Carvalho MG de, Braz-Filho R, Werle AA. Biflavonoids and a Glucopyranoside Derivative from Ouratea semiserrata. Phytochem Anal 2002;13:283-92.
13. Carvalho MG de, Velandia JR, De Oliveira MC, Echevarria A, Braz-Filho R, Grynberg NF. Chemical structure, cytotoxic and antitumour activities of biflavonoids from Brazilian ouratea (Ochnaceae). In: Phytochemical and Pharmacology II of the Series "Recent Progress in Medicinal Plants". Majumdar DK, Govil JN, Singh VK, editors. vol. 8, SCI Tech Publishing LLC: Texas, USA; 2002. p. 77-92.
14. Grynberg NF, Carvalho MG de, Velandia JR, Oliveira MC de, Moreira IC, Braz-Filho R, et al. DNA topoisomerase inhibitors: Biflavonoids from Ouratea species. Braz J Med Biol Res 2002;15:819-22.
15. Oliveira MC de, Carvalho MG de, Grynberg NF, Brioso PS. A Biflavonoid from Luxemburgia nobilis as inhibitor of DNA topoisomerases. Planta Med 2005;71:563-6.
16. Lee KH. Anticancer drug design based on plant-derived natural products. J Biomed Sci 1999;6:236-50.
17. Shi Q, Chen K, Chen X, Brossi A, Verdier-Pinard P, Hamel E, et al. Antitumor agents 183. Synthesis, conformational analysis, and antitubulin activity of allothiocolchicinoids. J Org Chem 1998;63:4018-25.
18. Iwu MM. Biflavanones of garcinia: Pharmacological, and biological activities in plant flavonoids in biologiy and medicine, biochemical, pharmacological, and structure-activity relationships. In: Cody V, Middleton E Jr, Harborne JB, editor. AR Liss, Inc: NY; 1986. p. 485-8.
19. Skehan P, Storeng R, Scudiero D, Monks A, Mcmahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Nat Cancer Inst 1990;82:1107-12.
20. Monks NR, Ferraz A, Bordgnon SA, Machado KR, Richter MF, da Rocha AB, et al. In vitro cytotoxicity of extracts from Brazilian asteraceae. Pharm Biol 2002;40:494-500.
21. Haberlein H, Tschiersch KP, Schafer HL. Flavonoids from Leptospermum scoparium with affinity to the benzodiazepine receptor characterized by structure activity relationships and in vivo studies of a plant extract. Pharmazie 1994;49:912-22.
22. Dimmock JR, Elias DW, Beazely MA, Kandepu NM. Bioactivities of chalcones. Curr Med Chem 1999;6:1125-49.
23. Yit CC, Das NP. Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. Cancer Lett 1994;82:65-72.